Spezielle Therapieformen

  • P. L. Bölcskei
  • M. Dreher
  • S. Ellis
  • L. Freitag
  • M. Höper
  • A.- M. Kirsten
  • P. Haidl
  • D. Köhler
  • T. Kramm
  • H. Magnussen
  • H. Matthys
  • H.-J. Schäfers
  • J. Storre
  • T. Welte
  • W. Windisch


Jede Sauerstoffgabe, die länger als 15 h/Tag über mehr als 3 Monate indiziert ist, bezeichnet man als Langzeitsauerstofftherapie (»long term oxygen therapy«, LTOT).


  1. Calverley PM, Walker P (2003) Chronic obstructive pulmonary disease. Lancet 362:1053–1061PubMedCrossRefGoogle Scholar
  2. Celli B, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23(6):932–946PubMedCrossRefGoogle Scholar
  3. Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM for the observatory group of ANTADIR (1996) Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. Chest 109:741–749PubMedCrossRefGoogle Scholar
  4. Chambellan A, Chailleux E, Similowski T, ANTADIR Observatory group (2005) Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 128(3):1201–1208PubMedCrossRefGoogle Scholar
  5. Croxton TL, Bailey WC for the NHLBI working group on long-term oxygen treatment in COPD (2006) Long term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research — an NHLBI workshop report. Am J Respir Crit Care Med 174:373–378PubMedCrossRefGoogle Scholar
  6. Eaton T, Garrett JE, Young P et al. (2002) Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 20(2):306–312PubMedCrossRefGoogle Scholar
  7. Global Strategy for diagnosis, management and prevention of chronic obstructive pulmonary disease (2006) www.goldcopd.comGoogle Scholar
  8. Gorecka D, Gorzelak K, Sliwinski P et al. (1997) Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 52(8):674–679PubMedCrossRefGoogle Scholar
  9. Lacasse R, Lecours C, Pelletier R, Begin, Maltais F (2005) Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 25(6):1032–1038PubMedCrossRefGoogle Scholar
  10. Magnussen H et al. (2001) Leitlinien zur Langzeit-Sauerstofftherapie. Pneumologie 55:454–464PubMedCrossRefGoogle Scholar
  11. Machado MC, Krishnan JA, Buist SA et al. (2006) Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174(5):524–529PubMedCrossRefGoogle Scholar
  12. Martis S, Munos X, Rios J et al (2006) Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 27(4):689–696CrossRefGoogle Scholar
  13. Medical Research Council Working Party (1981) Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1:681–686Google Scholar
  14. Nocturnal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease. Ann Intern Med 93:391–398Google Scholar
  15. Wijkstra PJ, Guyatt PH, Ambrosino N et al. (2001) International approaches to the prescription of long-term oxygen therapy. Eur Respir J 18(6):909–913PubMedCrossRefGoogle Scholar


  1. Boe J, Dennis JH, O’Driscoll BR (2001) European Respiratory Task Force: European Society Guidelines on the use of nebulizers. Eur Resp J 18:228–242CrossRefGoogle Scholar
  2. Dhand R (2005) Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients. Respir Care 50:1331–1334PubMedGoogle Scholar
  3. Dolovich MB, MacIntyre NR, Anderson PJ et al. (2000) Consensus statement: Aerosols and delivery devices. J Aerosol Med 13:291–300CrossRefPubMedGoogle Scholar
  4. Everard ML, Devadason SG, LeSouef PN (1997) Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler. Respir Med 91:624–628PubMedCrossRefGoogle Scholar
  5. Haidl P, Schmidt F, Wiese C, Köhler D (2006) Peak inspiratory flow rate after methacholine challenge in asthmatic patients and its impact on the effect of formoterol via different inhalers. J Aerosol Med 19:364–371PubMedCrossRefGoogle Scholar
  6. Kohlhäufl M, Haidl P, Voshaar Th et al. (2004) Pulverinhalationssysteme. Dtsch Med Wochenschr 129:2048–2052PubMedCrossRefGoogle Scholar
  7. Köhler D, Fleischer W (2000) Theorie und Praxis der Inhalationstherapie. Arcis, MünchenGoogle Scholar
  8. Lenney J, Innes JA, Crompton GK (2000) Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med 94:496–500PubMedCrossRefGoogle Scholar
  9. Matthys H (1998) Praxis der Aerosoltherapie. In: Scheuch G (Hrsg) Aerosole in der Aerosoltherapie II. Dustri, MünchenGoogle Scholar
  10. O’Riordan TG, Palmer LB, Smaldone GC (1994) Aerosol deposition in mechanically ventilated patients. Am J Respir Crit Care Med 149:214–219PubMedGoogle Scholar
  11. Patton JS, Bukar JG, Eldon MA (2004) Clinical pharmacokinetics and pharmacodynamics of inhaled insulin. Clin Pharmacokinet 43:781–801PubMedCrossRefGoogle Scholar
  12. Pauwels R, Newman S, Borgstrom L (1997) Airway deposition and airway effects of anti-asthmatic drugs delivered from metered-dose inhalers Eur Respir J 10:2127–2138PubMedCrossRefGoogle Scholar
  13. Schuepp KG, Straub D, Moller A, Wildhaber JH (2004) Deposition of aerosols in infants and children 17:153–156Google Scholar
  14. Voshaar Th (2005) Therapie mit Aerosolen. UNI-MED, BremenGoogle Scholar
  15. Voshaar Th, App EM, Berdel D et al. (2001) Empfehlungen für die Auswahl von Inhalationssystemen zur Medikamentenverabreichung. Pneumologie 55:579–586PubMedCrossRefGoogle Scholar


  1. American Thoracic Society (2001) International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure. Am J Respir Crit Care Med 163:283–91Google Scholar
  2. Anonymous (1999) Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation — a consensus conference report. Chest 116:521–34CrossRefGoogle Scholar
  3. Antonelli M, Conti G, Rocco M et al. (1998) A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 339:429–35PubMedCrossRefGoogle Scholar
  4. Antonelli M, Conti G, Moro ML et al. (2001) Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med 27:1718–28PubMedCrossRefGoogle Scholar
  5. Antonelli M, Conti G, Esquinas A et al. (2007) A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med 35:18–25PubMedCrossRefGoogle Scholar
  6. Brochard L, Mancebo J, Wysocki M et al. (1995) Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 333:817–22PubMedCrossRefGoogle Scholar
  7. Brochard L (2003) Mechanical ventilation: invasive versus noninvasive. Eur Respir J Suppl 47:31s–37sPubMedCrossRefGoogle Scholar
  8. Brochard L, Mancebo J, Elliott MW (2002) Noninvasive ventilation for acute respiratory failure. Eur Respir J 19:712–21PubMedCrossRefGoogle Scholar
  9. Buyse B, Meersseman W, Demedts M (2003) Treatment of chronic respiratory failure in kyphoscoliosis: oxygen or ventilation? Eur Respir J 22:525–8PubMedCrossRefGoogle Scholar
  10. Casanova C, Celli BR, Tost L et al. (2000) Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 118:1582–90PubMedCrossRefGoogle Scholar
  11. Clini E, Sturani C, Rossi A et al. (2002) The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 20:529–38PubMedCrossRefGoogle Scholar
  12. Conti G, Antonelli M, Navalesi P et al. (2002) Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial. Intensive Care Med 28:1701–7PubMedCrossRefGoogle Scholar
  13. Diaz O, Begin P, Torrealba B, Jover E, Lisboa C (2002) Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD. Eur Respir J 20:1490–8PubMedCrossRefGoogle Scholar
  14. Dreher M, Storre JH, Windisch W (2007) Noninvasive ventilation during walking in patients with severe COPD: a randomised cross-over trial. Eur Respir J 29:930–6PubMedCrossRefGoogle Scholar
  15. Elliott MW (2004) Non-invasive ventilation for acute respiratory disease. Br Med Bull 72:83–97PubMedCrossRefGoogle Scholar
  16. Esteban A, Frutos F, Tobin MJ et al. (1995) A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med 332:345–50PubMedCrossRefGoogle Scholar
  17. Esteban A, Frutos-Vivar F, Ferguson ND et al. (2004) Noninvasive positive-pressure ventilation for respiratory failure after extubation. N Engl J Med 350:2452–60PubMedCrossRefGoogle Scholar
  18. Ferrer M, Bernadich O, Nava S, Torres A. (2002) Noninvasive ventilation after intubation and mechanical ventilation. Eur Respir J 19:959–65PubMedCrossRefGoogle Scholar
  19. Ferrer M, Esquinas A, Arancibia F et al. (2003) Noninvasive ventilation during persistent weaning failure: a randomized controlled trial. Am J Respir Crit Care Med 168:70–6PubMedCrossRefGoogle Scholar
  20. Ferrer M, Valencia M, Nicolas JM, Bernadich O, Badia JR, Torres A (2006) Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med 173:164–70PubMedCrossRefGoogle Scholar
  21. Girault C, Daudenthun I, Chevron V, Tamion F, Leroy J, Bonmarchand G (1999) Noninvasive ventilation as a systematic extubation and weaning technique in acute-on-chronic respiratory failure: a prospective, randomized controlled study. Am J Respir Crit Care Med 160:86–92PubMedGoogle Scholar
  22. Hilbert G, Gruson D, Vargas F et al. (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–7PubMedCrossRefGoogle Scholar
  23. Hill NS (2004) Noninvasive ventilation for chronic obstructive pulmonary disease. Respir Care 49:72–87; discussion 87–9PubMedGoogle Scholar
  24. Janssens J, Derivaz S, Breitenstein E et al. (2003) Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest 123:67–79PubMedCrossRefGoogle Scholar
  25. Keenan SP, Sinuff T, Cook DJ, Hill NS (2004) Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med 32:2516–23PubMedCrossRefGoogle Scholar
  26. Lightowler JV, Wedzicha JA, Elliott MW, Ram FSF (2003) Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ 326:185PubMedCrossRefGoogle Scholar
  27. Lloyd-Owen SJ, Donaldson GC, Ambrosino N et al. (2005) Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 25:1025–31PubMedCrossRefGoogle Scholar
  28. Mehta S, Hill NS (2001) Noninvasive ventilation. Am J Respir Crit Care Med 163:540–77PubMedGoogle Scholar
  29. Nava S, Ceriana P (2004) Causes of failure of noninvasive mechanical ventilation. Respir Care 49:295–303PubMedGoogle Scholar
  30. Park M, Sangean MC, Volpe MdS et al. (2004) Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema. Crit Care Med 32:2407–15PubMedCrossRefGoogle Scholar
  31. Peter JV, Moran JL, Phillips-Hughes J, Graham P, Bersten AD (2006) Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet 367:1155–63PubMedCrossRefGoogle Scholar
  32. Plant PK, Owen JL, Elliott MW (2000) Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 355:1931–5PubMedCrossRefGoogle Scholar
  33. Schönhofer B, Kohler D (2000) Effect of non-invasive mechanical ventilation on sleep and nocturnal ventilation in patients with chronic respiratory failure. Thorax 55:308–13PubMedCrossRefGoogle Scholar
  34. Schönhofer B, Sortor-Leger S (2002) Equipment needs for noninvasive mechanical ventilation. Eur Respir J 20:1029–36PubMedCrossRefGoogle Scholar
  35. Schönhofer B (2006). Nicht-invasive Beatmung — Grundlagen und moderene Praxis, 1. Aufl. UNI-MED, BremenGoogle Scholar
  36. Simonds AK, Elliott MW (1995) Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 50:604–9PubMedCrossRefGoogle Scholar
  37. Simonds AK (2003) Home ventilation. Eur Respir J Suppl 47:38s–46sPubMedCrossRefGoogle Scholar
  38. Storre JH, Seuthe B, Fiechter R et al. (2006) Average volume-assured pressure support in obesity hypoventilation: A randomized crossover trial. Chest 130:815–21PubMedCrossRefGoogle Scholar
  39. Wijkstra PJ, Lacasse Y, Guyatt GH et al. (2003) A meta-analysis of nocturnal noninvasive positive pressure ventilation in patients with stable COPD. Chest 124:337–43PubMedCrossRefGoogle Scholar
  40. Winck JC, Azevedo LF, Costa-Pereira A, Antonelli M, Wyatt JC (2006) Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema — a systematic review and meta-analysis. Crit Care 10:R69PubMedCrossRefGoogle Scholar
  41. Windisch W, Kostic S, Dreher M, Virchow JCJ, Sorichter S (2005) Outcome of patients with stable COPD receiving controlled noninvasive positive pressure ventilation aimed at a maximal reduction of Pa(CO2). Chest 128:657–62PubMedCrossRefGoogle Scholar
  42. Windisch W, Dreher M, Storre JH, Sorichter S (2006) Nocturnal noninvasive positive pressure ventilation: Physiological effects on spontaneous breathing. Respir Physiol Neurobiol 150:251–60PubMedCrossRefGoogle Scholar


  1. Amato MB, Barbas CS, Medeiros DM et al. (1998) Effect of a protectiveventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338(6):347–354PubMedCrossRefGoogle Scholar
  2. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2(7511):319–323PubMedCrossRefGoogle Scholar
  3. Bein T, Weber F, Philipp A et al. (2006) A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 34(5):1372–1377PubMedCrossRefGoogle Scholar
  4. Borges JB, Okamoto VN, Matos GFJ et al. (2006) Reversibility of lung collapse and hypoxemia in early acute respiratory distress syndrome. Am J Respir Crit Care Med 174:268–278PubMedCrossRefGoogle Scholar
  5. Brochard L, Rauss A, Benito S et al. (1994) Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med 150:896–903PubMedGoogle Scholar
  6. Brower RG, Lanken PN, MacIntyre N et al. (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351(4):327–336PubMedCrossRefGoogle Scholar
  7. deJonge E, Schultz MJ, Spanjaard L, Bossuyt PMM, Vroom MB, Dankert J, Kesecioglu J (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized controlled trial. Lancet 362:1011–1016CrossRefGoogle Scholar
  8. Ely EW, Baker AM, Dunagan DP et al. (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. NEJM 335:1864–1869PubMedCrossRefGoogle Scholar
  9. Fischer S, Simon AR, Welte T, Hoeper MM, Meyer A, Tessmann R, Gorbandt B, Gottlieb J, Haverich A, Strueber M (2006) Bridge to lung transplantation with the novel pumpless interventional assist NovaLung. J Thorac Cardiovasc Surg 131:719–23PubMedCrossRefGoogle Scholar
  10. Gattinoni L, Agostoni A, Pesenti A et al. (1980) Treatment of acute respiratory failure with low-frequency positive-pressure ventilation and extracorporeal removal of CO2. Lancet 2(8189):292–294PubMedCrossRefGoogle Scholar
  11. Gattinoni L, Tognoni G, Pesenti A et al. (2001) Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 345:568–573PubMedCrossRefGoogle Scholar
  12. Gattinoni L, Vagginelli F, Carlesco E, Taccone P, Conte V, Chiumello D, Valenza F, Caironi P, Pesenti A (2003) Decrease in paCO2 with prone position is predictive of improved outcome in acute respiratory distress syndrome. Crit Care Med 31:2727–2733PubMedCrossRefGoogle Scholar
  13. Griffiths MJD, Evans TW (2005) Inhaled nitric oxide therapy in adults. N Engl J Med 353:2683–2695PubMedCrossRefGoogle Scholar
  14. Hager DN, Krishnan JA, Hayden DL, Brower RG (2005) Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 172:1241–1245PubMedCrossRefGoogle Scholar
  15. Hill JD, O’Brien TG, Murray JJ et al. (1972) Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shocklung syndrome). Use of the Bramson membrane lung. N Engl J Med 286(12):629–634PubMedGoogle Scholar
  16. Koeman M, van der Ven AJAM, Hak E et al. (2006) Oral decontamination with Chlorhexidin reduces the incidence of Ventilator-associated pneumonia. Am J Respir Crit Care Med 173:1348–1355PubMedCrossRefGoogle Scholar
  17. Kress, JP, Pohlmann AE, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477PubMedCrossRefGoogle Scholar
  18. Lellouche F, Mancebo J, Jolliet P et al. (2006) A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Resp Crit Care Med 174:894–900PubMedCrossRefGoogle Scholar
  19. MacIntyre NR, Cheng K-CG, McConnell R (1997) Applied PEEP during pressure support reduces the inspiratory threshold load of intrinsic PEEP. Chest 111:188–193PubMedCrossRefGoogle Scholar
  20. MacIntyre NR, Cook DJ, Guyatt GH (2001) Evidence based guidelines for weaning and discontinuing ventilatory support. American College of Chest Physicians, American Association for Respiratory Care, and American College of Critical Care Medicine. Chest 120(6 Suppl):375S–484SPubMedCrossRefGoogle Scholar
  21. Mancebo J, Fernández R, Blanch L et al. (2005) A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med 173:1233–1239CrossRefGoogle Scholar
  22. Morán I, Zavala E, Fernandez R, Blanch L, Mancebo J (2003) Recruitment manoeuvres in acute lung injury/acute respiratory distress syndrome. Eur Respir J 22:Suppl.42,37s–42sCrossRefGoogle Scholar
  23. Morris AH, Wallace CJ, Menlove RL et al. (1994) Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149(2 Pt 1):295–305PubMedGoogle Scholar
  24. Rumbak MJ, Newton M, Truncale T, Schwartz SW, Adams JW, Hazard PB (2004) A prospective, randomized study comparing early percutaneous dilational trecheotomy to prolonged transleryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med 32:1689–1694PubMedCrossRefGoogle Scholar
  25. The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRefGoogle Scholar
  26. The National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical trials Network (2004) Higher versus lower positive end expiratoy pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327–336CrossRefGoogle Scholar
  27. The National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical trials Network (2006) Efficiacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684CrossRefGoogle Scholar
  28. The National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical trials Network (2006) Pulmonaryartery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 354:2213–2224CrossRefGoogle Scholar
  29. The National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical trials Network (2006) Comparision of Two Fluid-Management Strategies in Acute Lung Injury. N Engl J Med 354:2564–2575CrossRefGoogle Scholar
  30. Spragg RG, Lewis JF, Walmrath HD et al. (2004) Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 351:884–892PubMedCrossRefGoogle Scholar
  31. Zapol WM, Snider MT, Hill JD et al. (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. Jama 242(20):2193–2196PubMedCrossRefGoogle Scholar


  1. [1]
    Toronto Lung Transplant Group (1986) Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 314:1140–5Google Scholar
  2. [2]
    The American Society for Transplant Physicians (ASTP)/ American Thoracic Society (ATS)/ European Respiratory Society (ERS)/ International Society for Heart and Lung Transplantation (ISHLT) (1998) International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 158:335–9Google Scholar
  3. [3]
    Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, Ekbom A, Adami HO, Granath F (2003) Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89:1221–7PubMedCrossRefGoogle Scholar
  4. [4]
    Aigner C, Winkler G, Jaksch P, Seebacher G, Lang G, Taghavi S, Wisser W, Klepetko W (2005) Extended donor criteria for lung transplantation — a clinical reality. Eur J Cardiothorac Surg 27:757–61PubMedCrossRefGoogle Scholar
  5. [5]
    Amital A, Shitrit D, Raviv Y, Bendayan D, Sahar G, Bakal I, Kramer MR (2006) Development of malignancy following lung transplantation. Transplantation 81:547–51PubMedCrossRefGoogle Scholar
  6. [6]
    Anthonisen NR (1989) Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Respir Dis 140:S95–9PubMedGoogle Scholar
  7. [7]
    Aris RM, Gilligan PH, Neuringer IP, Gott KK, Rea J, Yankaskas JR (1997) The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 155:1699–704PubMedGoogle Scholar
  8. [8]
    Armitage JM, Kurland G, Michaels M, Cipriani LA, Griffith BP, Fricker FJ (1995) Critical issues in pediatric lung transplantation. J Thorac Cardiovasc Surg 109:60–4; discussion 64–5PubMedCrossRefGoogle Scholar
  9. [9]
    Bando K, Armitage JM, Paradis IL et al. (1994) Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 108:1056–65PubMedGoogle Scholar
  10. [10]
    Bando K, Paradis IL, Keenan RJ et al. (1995) Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease. J Heart Lung Transplant 14:692–8PubMedGoogle Scholar
  11. [11]
    Bando K, Paradis IL, Similo S et al. (1995) Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 110:4–13; discussion 13–4PubMedCrossRefGoogle Scholar
  12. [12]
    Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS (1994) Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 121:409–15PubMedGoogle Scholar
  13. [13]
    Barten MJ, Rahmel A, Garbade J, Bold A, Bittner HB, Dhein S, Mohr FW, Gummert JF (2005) Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients. Transplant Proc 37:4532–4PubMedCrossRefGoogle Scholar
  14. [14]
    Bartz RR, Love RB, Leverson GE, Will LR, Welter DL, Meyer KC (2003) Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis. J Heart Lung Transplant 22:433–8PubMedCrossRefGoogle Scholar
  15. [15]
    Bavaria JE, Pochettino A, Kotloff RM, Rosengard BR, Wahl PM, Roberts JR, Palevsky HI, Kaiser LR (1998) Effect of volume reduction on lung transplant timing and selection for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 115:9–17; discussion 17–8PubMedCrossRefGoogle Scholar
  16. [16]
    Baz MA, Palmer SM, Staples ED, Greer DG, Tapson VF, Davis DD (2001) Lung transplantation after long-term mechanical ventilation: results and 1-year follow-up. Chest 119:224–7PubMedCrossRefGoogle Scholar
  17. [17]
    Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER (2000) Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 19:1199–204PubMedCrossRefGoogle Scholar
  18. [18]
    Burke CM, Theodore J, Dawkins KD et al. (1984) Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 86:824–9PubMedCrossRefGoogle Scholar
  19. [19]
    Caforio AL, Fortina AB, Piaserico S et al. (2000) Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 102:III222–7PubMedGoogle Scholar
  20. [20]
    Chacon RA, Corris PA, Dark JH, Gibson GJ (2000) Tests of airway function in detecting and monitoring treatment of obliterative transplantation in selected patients with coronary artery disease. J Thorac Cardiovasc Surg 124:1250–1Google Scholar
  21. [21]
    Connors AF Jr, Dawson NV, Thomas C et al. (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154:959–67PubMedGoogle Scholar
  22. [22]
    Cooper JD, Pearson FG, Patterson GA, Todd TR, Ginsberg RJ, Goldberg M, Waters P (1989) Use of silicone stents in the management of airway problems. Ann Thorac Surg 47:371–8PubMedGoogle Scholar
  23. [23]
    Cooper JD, Billingham M, Egan T et al. (1993) A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 12:713–6PubMedGoogle Scholar
  24. [24]
    Cooper JD, Patterson GA, Trulock EP (1994) Results of single and bilateral lung transplantation in 131 consecutive recipients. Washington University Lung Transplant Group. J Thorac Cardiovasc Surg 107:460–70; discussion 470-1PubMedGoogle Scholar
  25. [25]
    Cooper JD, Patterson GA, Sundaresan RS, Trulock EP, Yusen RD, Pohl MS, Lefrak SS (1996) Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 112:1319–29; discussion 1329-30PubMedCrossRefGoogle Scholar
  26. [26]
    Dahlman S, Jeppsson A, Schersten H, Nilsson F (2006) Expanding the donor pool: lung transplantation with donors 55 years and older. Transplant Proc 38:2691–3PubMedCrossRefGoogle Scholar
  27. [27]
    D’Alonzo GE, Barst RJ, Ayres SM et al. (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343–9PubMedGoogle Scholar
  28. [28]
    Davies HR, Richeldi L, Walters EH (2003) Immunomodulatory agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev: CD003134Google Scholar
  29. [29]
    De Hoyos A, Maurer JR (1992) Complications following lung transplantation. Semin Thorac Cardiovasc Surg 4:132–46PubMedGoogle Scholar
  30. [30]
    de Hoyos AL, Patterson GA, Maurer JR, Ramirez JC, Miller JD, Winton TL (1992) Pulmonary transplantation. Early and late results. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg 103:295–306PubMedGoogle Scholar
  31. [31]
    De Meester J, Smits JM, Persijn GG, Haverich A (1999) Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 18:563–71PubMedCrossRefGoogle Scholar
  32. [32]
    Detterbeck FC, Egan TM, Mill MR (1995) Lung transplantation after previous thoracic surgical procedures. Ann Thorac Surg 60:139–43PubMedGoogle Scholar
  33. [33]
    Dobbin C, Maley M, Harkness J, Benn R, Malouf M, Glanville A, Bye P (2004) The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect 56:277–82PubMedCrossRefGoogle Scholar
  34. [34]
    Doershuk CF, Stern RC (1999) Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival. Chest 115:782–7PubMedCrossRefGoogle Scholar
  35. [35]
    Duncan SR, Grgurich WF, Iacono AT et al. (1994) A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 150:146–52PubMedGoogle Scholar
  36. [36]
    Dusmet M, Winton TL, Kesten S, Maurer J (1996) Previous intrapleural procedures do not adversely affect lung transplantation. J Heart Lung Transplant 15:249–54PubMedGoogle Scholar
  37. [37]
    Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21:297–310PubMedCrossRefGoogle Scholar
  38. [38]
    Fein AM, Branman SS, Casaburi R, Irvin CG, Make BJ, Rodarte JR, Solway J (1996) Lung volume reduction surgery. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, May 1996. Am J Respir Crit Care Med 154:1151–2PubMedGoogle Scholar
  39. [39]
    Gammie JS, Keenan RJ, Pham SM, McGrath MF, Hattler BG, Khoshbin E, Griffith BP (1998) Single-versus double-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 115:397–402; discussion 402-3PubMedCrossRefGoogle Scholar
  40. [40]
    Garrity ER Jr, Mehra MR (2004) An update on clinical outcomes in heart and lung transplantation. Transplantation 77:S68–74PubMedCrossRefGoogle Scholar
  41. [41]
    Ghofrani HA, Wiedemann R, Rose F et al. (2002) Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360:895–900PubMedCrossRefGoogle Scholar
  42. [42]
    Groetzner J, Wittwer T, Kaczmarek I et al. (2006) Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation. Transplantation 81:355–60PubMedCrossRefGoogle Scholar
  43. [43]
    Hamm H (1995) Physiology, pathophysiology and clinical aspects of the pleural cavity. Revision of traditional models. Fortschr Med 113:283–4PubMedGoogle Scholar
  44. [44]
    Hanson D, Winterbauer RH, Kirtland SH, Wu R (1995) Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest 108:305–10PubMedCrossRefGoogle Scholar
  45. [45]
    Haverich A, Aziz S, Scott WC, Jamieson SW, Shumway NE (1986) Improved lung preservation using Euro-Collins solution for flushperfusion. Thorac Cardiovasc Surg 34:368–76PubMedCrossRefGoogle Scholar
  46. [46]
    Hoeper MM, Faulenbach C, Golpon H, Winkler J, Welte T, Niedermeyer J (2004) Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J 24:1007–10PubMedCrossRefGoogle Scholar
  47. [47]
    Ikonen T, Kivisaari L, Harjula AL et al. (1996) Value of high-resolution computed tomography in routine evaluation of lung transplantation recipients during development of bronchiolitis obliterans syndrome. J Heart Lung Transplant 15:587–95PubMedGoogle Scholar
  48. [48]
    Jamieson SW, Kapelanski DP, Sakakibara N et al. (2003) Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 76:1457–62; discussion 1462-4PubMedCrossRefGoogle Scholar
  49. [49]
    Jaramillo A, Smith MA, Phelan D et al. (1999) Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. Transplant Proc 31:185–6PubMedCrossRefGoogle Scholar
  50. [50]
    Joyal D, Cantarovich M, Cecere R, Giannetti N (2004) Early experience with two-dose daclizumab in the prevention of acute rejection in cardiac transplantation. Clin Transplant 18:493–6PubMedCrossRefGoogle Scholar
  51. [51]
    Keenan RJ, Lega ME, Dummer JS et al. (1991) Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 51:433–8PubMedGoogle Scholar
  52. [52]
    Kerem E, Reisman J, Corey M, Canny GJ, Levison H (1992) Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326:1187–91PubMedGoogle Scholar
  53. [53]
    Keshavjee SH, Yamazaki F, Yokomise H, Cardoso PF, Mullen JB, Slutsky AS, Patterson GA (1992) The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation. J Thorac Cardiovasc Surg 103:314–25PubMedGoogle Scholar
  54. [54]
    Khaghani A, Banner N, Ozdogan E et al. (1991) Medium-term results of combined heart and lung transplantation for emphysema. J Heart Lung Transplant 10:15–21PubMedGoogle Scholar
  55. [55]
    Klepetko W, Mayer E, Sandoval J et al. (2004) Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 43:73S–80SPubMedCrossRefGoogle Scholar
  56. [56]
    Kotloff RM, Zuckerman JB (1996) Lung transplantation for cystic fibrosis: special considerations. Chest 109:787–98PubMedCrossRefGoogle Scholar
  57. [57]
    Lee R, Meyers BF, Sundt TM, Trulock EP, Patterson GA (2002) Concomitant coronary artery revascularization to allow successful lung transplantation in selected patients with coronary artery disease. J Thorac Cardiovasc Surg 124:1250–1PubMedCrossRefGoogle Scholar
  58. [58]
    Levine SM, Jenkinson SG, Bryan CL, Anzueto A, Zamora CA, Gibbons WJ, Calhoon JH, Trinkle JK (1992) Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension. Chest 101:401–5PubMedCrossRefGoogle Scholar
  59. [59]
    Levine SM, Anzueto A, Peters JI, Calhoon JH, Jenkinson SG, Bryan CL (1994) Single lung transplantation in patients with systemic disease. Chest 105:837–41PubMedCrossRefGoogle Scholar
  60. [60]
    Levy RD, Ernst P, Levine SM et al. (1993) Exercise performance after lung transplantation. J Heart Lung Transplant 12:27–33PubMedGoogle Scholar
  61. [61]
    Lipson DA, Palevsky HI, Kotloff RM, Edelman J (1998) Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. Transplant Proc 30:1505–7PubMedCrossRefGoogle Scholar
  62. [62]
    Martinez JA, Paradis IL, Dauber JH et al. (1997) Spirometry values in stable lung transplant recipients. Am J Respir Crit Care Med 155:285–90PubMedGoogle Scholar
  63. [63]
    McKenna RJ, Jr., Brenner M, Fischel RJ, Gelb AF (1996) Should lung volume reduction for emphysema be unilateral or bilateral? J Thorac Cardiovasc Surg 112:1331–8; discussion 1338-9PubMedCrossRefGoogle Scholar
  64. [64]
    Mendeloff EN, Meyers BF, Sundt TM et al. (2002) Lung transplantation for pulmonary vascular disease. Ann Thorac Surg 73:209–17; discussion 217-9PubMedCrossRefGoogle Scholar
  65. [65]
    Meyer DM, Bennett LE, Novick RJ, Hosenpud JD (2001) Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 20:935–41PubMedCrossRefGoogle Scholar
  66. [66]
    Meyer DM, Edwards LB, Torres F, Jessen ME, Novick RJ (2005) Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann Thorac Surg 79:950–7; discussion 957-8PubMedCrossRefGoogle Scholar
  67. [67]
    Meyers BF, Lynch JP, Battafarano RJ, Guthrie TJ, Trulock EP, Cooper JD, Patterson GA (2000) Lung transplantation is warranted for stable, ventilator-dependent recipients. Ann Thorac Surg 70:1675–8PubMedCrossRefGoogle Scholar
  68. [68]
    Morrish WF, Herman SJ, Weisbrod GL, Chamberlain DW (1991) Bronchiolitis obliterans after lung transplantation: findings at chest radiography and high-resolution CT. The Toronto Lung Transplant Group. Radiology 179:487–90PubMedGoogle Scholar
  69. [69]
    Neumayer HH (2005) Introducing everolimus (Certican) in organ transplantation: an overview of preclinical and early clinical developments. Transplantation 79:S72–5PubMedCrossRefGoogle Scholar
  70. [70]
    Niedermeyer J, Bewig B, Bickhardt T et al. (2001) Lung and heartlung transplantation. Guidelines for indications and preoperative diagnosis. Pneumologie 55:396–400PubMedCrossRefGoogle Scholar
  71. [71]
    Novick RJ, Andreassian B, Schafers HJ et al. (1994) Pulmonary retransplantation for obliterative bronchiolitis. Intermediate-term results of a North American-European series. J Thorac Cardiovasc Surg 107:755–63PubMedGoogle Scholar
  72. [72]
    Olschewski H, Simonneau G, Galie N et al. (2002) Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347:322–9PubMedCrossRefGoogle Scholar
  73. [73]
    Orens JB, Estenne M, Arcasoy S et al. (2006) International guidelines for the selection of lung transplant candidates: 2006 update — a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 25:745–55PubMedCrossRefGoogle Scholar
  74. [74]
    Palmer SM, Miralles AP, Lawrence CM, Gaynor JW, Davis RD, Tapson VF (1999) Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. Chest 116:127–33PubMedCrossRefGoogle Scholar
  75. [75]
    Pasque MK, Cooper JD, Kaiser LR, Haydock DA, Triantafillou A, Trulock EP (1990) Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg 49:785–91PubMedGoogle Scholar
  76. [76]
    Patterson GA, Cooper JD, Goldman B et al. (1988) Technique of successful clinical double-lung transplantation. Ann Thorac Surg 45:626–33PubMedGoogle Scholar
  77. [77]
    Patterson GM, Wilson S, Whang JL, Harvey J, Agacki K, Patel H, Theodore J (1996) Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 15:175–81PubMedGoogle Scholar
  78. [78]
    Penn I (1990) Cancers complicating organ transplantation. N Engl J Med 323:1767–9PubMedGoogle Scholar
  79. [79]
    Penn I (1993) Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 12:S328–36PubMedGoogle Scholar
  80. [80]
    Pham SM, Qi XS, Mallon SM et al. (2002) Sirolimus and tacrolimus in clinical cardiac transplantation. Transplant Proc 34:1839–42PubMedCrossRefGoogle Scholar
  81. [81]
    Pochettino A, Kotloff RM, Rosengard BR, Arcasoy SM, Blumenthal NP, Kaiser LR, Bavaria JE (2000) Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg 70:1813–8; discussion 1818-9PubMedCrossRefGoogle Scholar
  82. [82]
    Puskas JD, Hirai T, Christie N, Mayer E, Slutsky AS, Patterson GA (1992) Reliable thirty-hour lung preservation by donor lung hyperinflation. J Thorac Cardiovasc Surg 104:1075–83PubMedGoogle Scholar
  83. [83]
    Quantz MA, Bennett LE, Meyer DM, Novick RJ (2000) Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations. J Heart Lung Transplant 19:473–9PubMedCrossRefGoogle Scholar
  84. [84]
    Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM (2003) Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Chest 124:1242–9PubMedCrossRefGoogle Scholar
  85. [85]
    Reichenspurner H (2005) Overview of tacrolimus-based immunosuppression after heart or lung transplantation. J Heart Lung Transplant 24:119–30PubMedCrossRefGoogle Scholar
  86. [86]
    Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, Stinson EB, Shumway NE (1982) Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 306:557–64PubMedGoogle Scholar
  87. [87]
    Revell MP, Lewis ME, Llewellyn-Jones CG, Wilson IC, Bonser RS (2000) Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation. J Heart Lung Transplant 19:1219–23PubMedCrossRefGoogle Scholar
  88. [88]
    Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P (2000) Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med 161:1924–9PubMedGoogle Scholar
  89. [89]
    Rubin LJ, Badesch DB, Barst RJ et al. (2002) Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346:896–903PubMedCrossRefGoogle Scholar
  90. [90]
    Saiman L, Mehar F, Niu WW, Neu HC, Shaw KJ, Miller G, Prince A (1996) Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis 23:532–7PubMedGoogle Scholar
  91. [91]
    Schafers HJ, Haydock DA, Cooper JD (1991) The prevalence and management of bronchial anastomotic complications in lung transplantation. J Thorac Cardiovasc Surg 101:1044–52PubMedGoogle Scholar
  92. [92]
    Schwartz DA, Van Fossen DS, Davis CS, Helmers RA, Dayton CS, Burmeister LF, Hunninghake GW (1994) Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 149:444–9PubMedGoogle Scholar
  93. [93]
    Seersholm N, Kok-Jensen A, Dirksen A (1994) Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases. Thorax 49:695–8PubMedCrossRefGoogle Scholar
  94. [94]
    Seoane L, Arcement LM, Valentine VG, McFadden PM (2005) Long-term survival in lung transplant recipients after successful preoperative coronary revascularization. J Thorac Cardiovasc Surg 130:538–41PubMedCrossRefGoogle Scholar
  95. [95]
    Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J (1996) Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation — early risk factors. Transplantation 61:560–6PubMedCrossRefGoogle Scholar
  96. [96]
    Smith CM (1997) Patient selection, evaluation, and preoperative management for lung transplant candidates. Clin Chest Med 18:183–97PubMedCrossRefGoogle Scholar
  97. [97]
    Smith MA, Sundaresan S, Mohanakumar T et al. (1998) Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 116:812–20PubMedCrossRefGoogle Scholar
  98. [98]
    Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR (1993) Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 103:466–71PubMedCrossRefGoogle Scholar
  99. [99]
    Snell GI, Richardson M, Griffiths AP, Williams TJ, Esmore DS (1999) Coronary artery disease in potential lung transplant recipients > 50 years old: the role of coronary intervention. Chest 116:874–9PubMedCrossRefGoogle Scholar
  100. [100]
    Snell GI, Levvey BJ, Zheng L, Bailey M, Orsida B, Law L, Whitford HM, Kotsimbos TC, Williams TJ (2005) Everolimus alters the bronchoalveolar lavage and endobronchial biopsy immunologic profile post-human lung transplantation. Am J Transplant 5:1446–51PubMedCrossRefGoogle Scholar
  101. [101]
    Soghikian MV, Valentine VG, Berry GJ, Patel HR, Robbins RC, Theodore J (1996) Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. J Heart Lung Transplant 15:881–7PubMedGoogle Scholar
  102. [102]
    Speich R, Thurnheer R, Gaspert A, Weder W, Boehler A (1999) Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation. Transplantation 67:315–20PubMedCrossRefGoogle Scholar
  103. [103]
    Spray TL, Mallory GB, Canter CE, Huddleston CB, Kaiser LR (1992) Pediatric lung transplantation for pulmonary hypertension and congenital heart disease. Ann Thorac Surg 54:216–23; discussion 224-5PubMedCrossRefGoogle Scholar
  104. [104]
    Thabut G, Mal H, Castier Y, Groussard O, Brugiere O, Marrash-Chahla R, Leseche G, Fournier M (2003) Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 126:469–75PubMedCrossRefGoogle Scholar
  105. [105]
    Treede H, Klepetko W, Reichenspurner H, Zuckermann A, Meiser B, Birsan T, Wisser W, Reichert B (2001) Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. J Heart Lung Transplant 20:511–7PubMedCrossRefGoogle Scholar
  106. [106]
    Trulock EP (1993) Management of lung transplant rejection. Chest 103:1566–76PubMedCrossRefGoogle Scholar
  107. [107]
    Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI (2006) Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report 2006. J Heart Lung Transplant 25:880–92PubMedCrossRefGoogle Scholar
  108. [108]
    Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH (2002) Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 21:731–7PubMedCrossRefGoogle Scholar
  109. [109]
    Walter N, Collard HR, King TE Jr (2006) Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3:330–8PubMedCrossRefGoogle Scholar
  110. [110]
    Weill D, Torres F, Hodges TN, Olmos JJ, Zamora MR (1999) Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. J Heart Lung Transplant 18:1080–7PubMedCrossRefGoogle Scholar
  111. [111]
    Yankaskas JR, Mallory GB Jr (1998) Lung transplantation in cystic fibrosis: consensus conference statement. Chest 113:217–26PubMedCrossRefGoogle Scholar
  112. [112]
    Yonan NA, el-Gamel A, Egan J, Kakadellis J, Rahman A, Deiraniya AK (1998) Single lung transplantation for emphysema: predictors for native lung hyperinflation. J Heart Lung Transplant 17:192–201PubMedGoogle Scholar


  1. Beamis JF, Mathur PN, Mehta A (Hrsg.) (2004) Interventional Pulmonary Medicine. Dekker, New YorkGoogle Scholar
  2. Bolliger CT, Mathur PN (Hrsg.) (2000) Interventional Bronchoscopy. Karger, BaselGoogle Scholar
  3. Bolliger CT, Sutedja TG, Strausz J, Freitag L (2006) Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Europ Respir J 27(6):1258–71CrossRefGoogle Scholar
  4. Deutsche Gesellschaft für Pneumologie (1998) Empfehlungen zur bronchoskopischen Behandlung tracheobronchialer Verschlüsse, Stenosen und muraler maligner Tumoren. Pneumologie 52:243–248Google Scholar
  5. Dobbertin I, Dierkesmann R (Hrsg.) (2004) Lehrbuch und Atlas der Bronchoskopie. Huber, BernGoogle Scholar
  6. Freitag L, Macha HN, Loddenkemper R (2001) Interventional bronchoscopic procedures. In: Spiro SG (ed.) Lung Cancer. European Respiratory Monograph 6(17):272–304Google Scholar
  7. Freitag L, Macha NH (2004) Hämoptysen. Internist 45(5):555–64PubMedCrossRefGoogle Scholar
  8. Freitag L (2006) Bronchoskopie auf der Intensivstation. In: Zerkowski HR, Baumann G (Hrsg.) Herzakutmedizin. Steinkopff, Darmstadt, 2006Google Scholar
  9. Kollofrath O (1897 ) Entfernung eines Knochenstücks aus dem rechten Bronchus auf natürlichem Wege und unter Anwendung der directen Laryngoscopie. MMW 38:1038–1039Google Scholar
  10. Prakash UBS (Hrsg.) (1994) Bronchoscopy. Raven Press, New YorkGoogle Scholar
  11. Rodriguez-Panadero F, Janssen JP, Astoul P (2006) Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur Respi J 28:409–421CrossRefGoogle Scholar


  1. ATS (1994) Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 149:1359–1374Google Scholar
  2. Demers C, Grissberg JS (1992) Deep venous thrombosis and pulmonary embolism in pregnancy. Clin Chest Med 13:645–656PubMedGoogle Scholar
  3. Hanania NA, Cazzola M (2006) Acute espiratory failure in Pregnancy. In: Narva S, Welte T (eds.) Respiratory emergencies. Eur Respir Mon 36:241–258Google Scholar
  4. King TE Jr (1992) Restrictive lung disease in pregnancy. Clin Chest Med 13:607–622PubMedGoogle Scholar
  5. Koboloff RM, Fitz Simmons SC, Fiel SB (1992) Fertility and pregnancy in patients with cystic fibrosis. Clin Chest Med 13:607–622Google Scholar
  6. Laube DI, Poceta JS, Morales MC, Peacocr MD, Mitler MM (1996) Self reported snoring in pregnancy. Association with fetal outcome. Chest 109:885–889CrossRefGoogle Scholar
  7. Mapp C, Buist S (eds.) (2003) Respiratory diseases in women. Eur Respir Mon 25Google Scholar
  8. Minerbi-Codish I, Fraser D, Avnun L, Glezerman M, Heimer D (1998) Influence of Asthma in Pregnancy on Labor and the Newborn. Respiration 65:130–135PubMedCrossRefGoogle Scholar
  9. Neumann SM, Freyschmidt J, Holland BR, Henschel M, Gahnem NR (1997) Vergleich der Perfusions-Ventilations-Szintigraphie mit dem Spiral-CT bei akuter Lungenembolie. Med Klin 92:635–641Google Scholar
  10. Olesen C, Thrane N, Soerensen HAT, Olsen J (2001) A population-based study of asthma drugs during pregnancy: changing the intensity of asthma therapy and perinatal outcomes. Respiration 68:256–261PubMedCrossRefGoogle Scholar
  11. Jeldio SM (1992) Dyspnoea during pregnancy distinguising cardiac from pulmonary causes. Clin Chest Med 13:567–585Google Scholar
  12. Rigk N, Kalassian KG, Gilligan T, Drazin MI, Daniel DL (1996) Obstetric complications in pulmonary and critical care medicine. Chest 110:791–809CrossRefGoogle Scholar
  13. Rodriguez I, Niedermann MS (1992) Pneumonie complicating pregnancy. Clin Chest Med 13:679–691Google Scholar
  14. Semedstad KG, Cramb R, Morrison DH (1994) Pulmonary hypertension and pregnancy, a series of 8 cases. Can J Anaesth 41:502–512Google Scholar
  15. Stenius-Arniala B, Pürila P, Teramo K (1988) Asthma and pregnancy a prospective study of 198 pregnancies. Thorax 43:12–18CrossRefGoogle Scholar
  16. Wurm K (Hrsg) (1997) Sarkoidose. Thieme, StuttgartGoogle Scholar


  1. Batra A, Schütz CG, Lindinger P (2006) Tabakabhängigkeit. In: Schmidt LG, Gaspar M, Falkai P, Gaebel W (Hrsg.) Evidenzbasierte Suchtmedizin. Behandlungsleitlinie Substanzbezogene Störungen. Deutscher Ärzteverlag, Köln, S. 91–142Google Scholar
  2. Bölcskei PL (2004) Tabakentwöhnung: Kritische Bestandsaufnahme und Chancen für die Zukunft. Pneumologie 58:137–139PubMedCrossRefGoogle Scholar
  3. Britton J (Hrsg.) (2004) ABC of Smoking cessation. BMJ Books, Blackwell, OxfordGoogle Scholar
  4. Cahill K, Stead LF, Lancaster T (2007) Nicotine receptor partial agonists for smoking cassation. Cochrane Database of Systematic Reviews Issue 1. Wiley, ChichesterGoogle Scholar
  5. Cokkinides V et al. (2006) Progress and Opportunities in Tobacco Control. CA Cancer J Clin 56:135–142PubMedCrossRefGoogle Scholar
  6. Cornuz J, Humair JP, Zellweger JP (2004) Tabakentwöhnung 1. Teil: Wie es geht und was es bringt. Schweiz Med Forum 4:764–770Google Scholar
  7. Cornuz J, Humair JP, Zellweger JP (2004) Tabakentwöhnung 2. Teil: Empfehlungen für die tägliche Praxis. Schweiz Med Forum 4:792–805Google Scholar
  8. Deutsches Krebsforschungszentrum (Hrsg.) (2003) Passivrauchende Kinder in Deutschland — Frühe Schädigungen für ein ganzes Leben. DKFZ, HeidelbergGoogle Scholar
  9. Deutsches Krebsforschungszentrum (Hrsg.) (2003) Tabaksteuererhöhungen — Fakten und Argumente. DKFZ, Heidelberg, 2003Google Scholar
  10. Deutsches Krebsforschungszentrum (Hrsg.) (2005) Passivrauchen — ein unterschätztes Gesundheitsrisiko. DKFZ, Heidelberg, 2005Google Scholar
  11. Fiore MC et al. (2000) Treating Tobacco Use and Dependence. Clinical Practice Guideline, U.S. Department of Health and Human Services, Washington DCGoogle Scholar
  12. Fletcher C, Peto R (1977) The natural history of chronic airflow obstruction. Brit Med J 1:1645–1648PubMedCrossRefGoogle Scholar
  13. Gervais A et al. (2006) Milestones in the natural course of onset of cigarette use among adolescents. CMAJ 175(3):255 ffGoogle Scholar
  14. Gonzales D et al. (2006) Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partila Agonist, vs Substained-Release Bupropion and Placebo for Smoking Cessation. JAMA 296(1):47–55PubMedCrossRefGoogle Scholar
  15. Henley SJ et al. (2007) Tabacco-related disease mortality among men who switched from cigarettes to spit tabacco. Tabacco-Control 16(1):22–8CrossRefGoogle Scholar
  16. Hering T, Bölcskei PL (2002) Raucher in der Praxis entwöhnen. Ein neues Programm ist in über 50% erfolgreich. MMW-Fortschr Med 18:50–51Google Scholar
  17. Hughes JR, Stead LF, Langester T (2007) Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, Issue 1, Wiley, ChichesterGoogle Scholar
  18. Lancaster T, Stead L, Cahill K (2008) An update on therapeutics for tobacco dependence. Expert opinion on pharmacotherapy 9:15–22PubMedCrossRefGoogle Scholar
  19. LeSage MG, Keyler DE, Pentel PR (2006) Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies. AAPS J 8(1):E65–75PubMedCrossRefGoogle Scholar
  20. Lob-Corzilius T (2006) Gesundheitsgefahren durch Tabakrauchbelastung von Kindern. Nicorette Science 3:2–4Google Scholar
  21. Maurer P, Bachmann MF (2007) Vaccination against nicotine: an emerging therapy for tobacco dependence. Expert opinion on investigational drugs 16:1775–1783PubMedCrossRefGoogle Scholar
  22. Miller WR & Rollnick S (2004) Motivierende Gesprächsführung. Lambertus: FreiburgGoogle Scholar
  23. National Institute for Health and Clinical Excellence (NHS) (2002) Smoking cessation — bupropion and nicotine replacement therapy. Guidance type: Technology Appraisal TA39Google Scholar
  24. Neubauer S et al. (2006) Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tobacco Control 15:464–471PubMedCrossRefGoogle Scholar
  25. ÖGAM (2007) Konsensus Statement: Raucherentwöhnung in der allgemeinmedizinischen Praxis. 2. erw. Aufl. Intern Z ärztl Fortb 3Google Scholar
  26. Österreichische Gesellschaft für Pneumologie (ÖGP) (2005) Standards der Raucherentwöhnung. Konsensus der ÖGP. Wiener Klinische Wochenschrift (Suppl.2) 117:1–18Google Scholar
  27. Prochaska JO, DiClemente CC, Norcross JC (1992) In search how people change. Applications to addictive behaviors. American Psychologist 47(9):1102–1114PubMedCrossRefGoogle Scholar
  28. Raupach T, Nowak D, Hering T, Batra A, Andreas S (2007) Rauchen und pneumologische Erkrankungen, positive Effekte der Tabakentwöhnung. Pneumologie 61:11–14PubMedCrossRefGoogle Scholar
  29. Silagy C, Lancaster T, Stead LF, Mant D, Fowler G (2005) Nicotine replacement therapy for smoking cessation (Review). Cochrane Library Issue 4, Wiley, ChichesterGoogle Scholar
  30. Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M, Sutherland G (2008) Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction 103:146–154PubMedCrossRefGoogle Scholar
  31. Statistisches Bundesamt (Hrsg.) (2006) Leben in Deutschland. Haushalte, Familien und Gesundheit — Ergebnisse des Mikrozensus 2005. Statistisches Bundesamt, WiesbadenGoogle Scholar
  32. Stead LF, Lancaster T (2005 ) Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews: Reviews, Issue 2, Wiley, ChichesterGoogle Scholar
  33. Stead LF, Lancaster T (2007) Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews, Issue 4, Wiley, ChichesterGoogle Scholar
  34. Tashkin D, Kanne R, Bailey W et al. (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double blind placebo-controlled randomised trial. Lancet 357:1571–1575PubMedCrossRefGoogle Scholar
  35. Thürauf N (2005) Der Schalter zur Sucht: Neue Einblicke in die Tabakabhängigkeit. Nicorette Science 3:2–4Google Scholar
  36. Tverdal A, Bjartveit K (2006). Health consequences of reduced daily cigarette consumption. Tobacco Control 15:472–480PubMedCrossRefGoogle Scholar
  37. Wennike P, Danielsson T, Landfeldt B, Westin A, Tonnesen P (2003) Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction 98:1395–1402PubMedCrossRefGoogle Scholar
  38. West R, Sohal T (2006) »Catastrophic« pathways to smoking cessation: findings from national survey. BMJ 332:458–460PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2008

Authors and Affiliations

  • P. L. Bölcskei
    • 1
  • M. Dreher
    • 2
  • S. Ellis
    • 3
  • L. Freitag
    • 4
  • M. Höper
    • 3
  • A.- M. Kirsten
    • 5
  • P. Haidl
    • 6
  • D. Köhler
    • 6
  • T. Kramm
    • 7
  • H. Magnussen
    • 8
  • H. Matthys
    • 9
  • H.-J. Schäfers
    • 7
  • J. Storre
    • 2
  • T. Welte
    • 3
  • W. Windisch
    • 2
  1. 1.Institut für Raucherberatung und TabakentwöhnungMünchen
  2. 2.Medizinische Klinik Abteilung PneumologieUniversitätsklinikum FreiburgFreiburg
  3. 3.Abteilung PneumologieMedizinische Hochschule HannoverHannover
  4. 4.Lungenklinik HemerHemer
  5. 5.Zentrum für Pneumologie und ThoraxchirurgiePneumologisches Forschungsinstitut am Krankenhaus GroßhansdorfGroßhansdorf
  6. 6.Zentrum für Pneumologie, Allergologie, Beatmungs- und SchlafmedizinFachkrankenhaus Kloster GrafschaftSchmallenberg/Grafschaft
  7. 7.Klinik für Thorax- und Herz-GefäßchirurgieUniversitätsklinikum des SaarlandesHomburg
  8. 8.Krankenhaus GroßhansdorfGroßhansdorf
  9. 9.Freiburg

Personalised recommendations